Celon Pharma S.A. at the JP Morgan Investor Conference 2020

This year's conference will be held between 13 and 16 January 2020 in San Francisco. Representatives of the Company’s Management Board will participate in the event.

Maciej Wieczorek, CEO of Celon Pharma S.A.: This year, we are focusing on continuing the talks regarding a partnership agreement for esketamine DPI. The schedule of the phase II clinical trial does not currently affect the subject of the ongoing talks. In line with our strategy of global commercialisation of our innovation portfolio, in response to numerous questions and interest from investors, we are planning meetings concerning other projects in the field of neurology and metabolic diseases.

Annual meetings held as part of the JP Morgan Healthcare Conference are the largest event of its kind, bringing together investors, leaders and creators of modern technologies in the field of life science.